Newsroom

Home / Newsroom / Addition of a Second Clinical Site in the Expansion of its Chimeric Antigen Receptor T-cell (CAR-T) Phase I Clinical Trial for Its CARD-1 Trial
15May

Addition of a Second Clinical Site in the Expansion of its Chimeric Antigen Receptor T-cell (CAR-T) Phase I Clinical Trial for Its CARD-1 Trial

Download Full Article as .PDF (Size: 188 kB)

This CBMG article was posted on 15 May 2017